Gastroenterologically relevant high alert medications prescribed to children with chronic diseases—a consensus-driven single-center pilot study - Takeaways - MDSpire

Gastroenterologically relevant high alert medications prescribed to children with chronic diseases—a consensus-driven single-center pilot study

  • By

  • Judith Hochrainer

  • Rebecca Einspieler

  • Andreas Heilos

  • Judith Pichler

  • Michael Boehm

  • May 4, 2026

  • 0 min

Share

  • 1

    The study identified High Alert Medications (HAMs) in pediatric gastroenterology using a consensus approach among interdisciplinary teams.

  • 2

    A total of 32 medications were categorized into high-risk categories, with 12 identified as HAMs, primarily including immunosuppressants.

  • 3

    Half of the identified HAMs were only listed in one other published source, highlighting the need for localized medication safety lists.

  • 4

    The study emphasizes the importance of considering both medication risk and patient-specific factors in assessing potential harm.

  • 5

    Validation studies are necessary to generalize findings and improve medication safety frameworks for pediatric patients at home.

Original Source(s)

Gastroenterologically relevant high alert medications prescribed to children with chronic diseases—a consensus-driven single-center pilot study

  • by Judith Hochrainer, Rebecca Einspieler, Andreas Heilos, Judith Pichler, Michael Boehm

  • May 4, 2026

Related Content

Electroencephalographic abnormalities and clinical phenotypes in children with autism spectrum disorder: a single center cohort study

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Isoflurane for difficult sedation in critically ill children: a retrospective analysis in a mixed pediatric intensive care population